Search Within

Antonio Marra

Formats
  1. Journal Article (28)
  2. Meeting Abstract (16)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (46)
  2. Department of Pathology and Laboratory Medicine (35)
  3. GSK Faculty (34)
  4. Department of Medicine (32)
  5. Solid Tumor Oncology Division (32)
  6. Graduate Medical Education (25)

More Groups

People
  1. Jorge Reis-Filho (30)
  2. Pier Selenica (26)
  3. Britta Weigelt (22)
  4. Fresia Pareja Zea (20)
  5. Andrea Gazzo (18)
  6. Hannah Wen (16)

More People

Years
  1. 2025 (3)
  2. 2024 (8)
  3. 2023 (15)
  4. 2022 (19)
  5. 2021 (1)
Publications
  1. Annals of Oncology (6)
  2. Journal of Clinical Oncology (6)
  3. Modern Pathology (5)
  4. Laboratory Investigation (4)
  5. npj Breast Cancer (3)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. Nature Publishing Group (9)
  2. Oxford University Press (7)
  3. American Association for Cancer Research (6)
  4. American Society of Clinical Oncology (6)
  5. Nature Research (5)
  6. Elsevier B.V. (2)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Marra, A.; Gazzo, A.; Gupta, A.; Selenica, P.; Da Silva, E. M.; Pareja, F.; Pei, X.; Zhu, Y.; Razavi, P.; Safonov, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
    Journal Article

    Selenica, P.; Marra, A.; Choudhury, N. J.; Gazzo, A.; Falcon, C. J.; Patel, J.; Pei, X.; Zhu, Y.; Ng, C. K. Y.; Curry, M.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents
    Meeting Abstract

    Tarantino, P.; D'Ecclesiis, O.; Nicolo, E.; Antonarelli, G.; Bielo, L. B.; Marra, A.; Gandini, S.; Crimini, E.; Giugliano, F.; Zagami, P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer
    Meeting Abstract

    Safonov, A. M.; Bandlamudi, C.; Selenica, P.; Marra, A.; Ferraro, E.; Mandelker, D.; Solit, D. B.; Berger, M. F.; Norton, L.; Powell, S. N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cell-free DNA analysis as a molecular tool to monitor response to immune checkpoint inhibition in endometrial cancer
    Meeting Abstract

    Manning-Geist, B.; Patel, J. A. A.; Marra, A.; Da Cruz Paula, A.; Hanlon, E. J.; Abu-Rustum, N.; Shah, R. H.; Berger, M. F.; Hensley, M. L.; Zamarin, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Meeting Abstract

    Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: A case series
    Journal Article

    Sia, T. Y.; Manning-Geist, B.; Gordhandas, S.; Murali, R.; Marra, A.; Liu, Y. L.; Friedman, C. F.; Hollmann, T. J.; Zivanovic, O.; Chi, D. S.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas
    Journal Article

    Ross, D. S.; Devereaux, K. A.; Jin, C.; Lin, D. Y. T.; Zhang, Y.; Marra, A.; Makker, V.; Weigelt, B.; Ellenson, L. H.; Chui, M. H.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • ATM germline-mutated gastroesophageal junction adenocarcinomas: Clinical descriptors, molecular characteristics, and potential therapeutic implications
    Journal Article

    El Jabbour, T.; Misyura, M.; Cowzer, D.; Zimmermann, M.; Rimkunas, V.; Marra, A.; Derakhshan, F.; Selenica, P.; Parilla, M.; Setton, J. S.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • The spectrum of breast cancer with TERT genetic alterations
    Meeting Abstract

    Colon Cartagena, L.; Gazzo, A.; da Silva, E. M.; Derakhshan, F.; Marra, A.; Ross, D.; D'Alfonso, T.; Zhang, H.; Wen, H.; Weigelt, B.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save